当前位置： SCI文献检索 > EXPERIMENTAL CELL RESEARCH期刊下所有文献 > MicroRNA-92a -mediated endothelial to mesenchymal transition controls vein graft neointimal lesion formation.

MicroRNA-92a -mediated endothelial to mesenchymal transition controls vein graft neointimal lesion formation.

Abstract：

PURPOSE:Long-term failure of vein grafts due to neointimal hyperplasia remains an important problem in coronary artery bypass graft surgery. Endothelial to mesenchymal transition (EndMT) contributes to vein graft vascular remodeling. However, there is little study on microRNA-mediated EndMT contributions to neointimal formation in vein graft. We hypothesized that microRNA-92a (miR-92a) might play an important role in determining EndMT contributions to neointimal formation. METHODS:miR-92a and EndMT-related proteins detected by qRT-PCR and Western blot in vitro and in vivo. Adeno-associated virus 6 (AAV6) delivery gene therapy was used to inhibit neointimal formation in vivo. The intimal hyperplasia of vein grafts was measured by HE staining, the expression of EndMT-related protein in vein grafts was measured by immunofluorescence. Immunohistochemistry and luciferase assay were used to detect potential targets of miR-92a. RESULTS:The expression of miR-92a was found to be upregulated in neointimal hyperplasic lesions after vein grafting. Using cultured human umbilical vein endothelial cells (HUVECs), we show that TGF-β1 treatment of HUVECs significantly increased miR-92a expression and induced EndMT, characterized by suppression of endothelial-specific markers (CD31 and VE-cadherin) and an increase in mesenchymal-specific markers (a-SMA and vimentin), while inhibition of miR-92a expression blunted EndMT in cultured HUVECs. Furthermore, AAV6 mediated miR-92a suppression gene therapy effectively resulted in decreased EndMT and less neointimal formation in vein grafts in vivo. We further identified that integrin alpha 5 (ITGA5) is a potential target gene involved in the development of neointima formation in these vein grafts. CONCLUSION:This data suggests that neointimal formation does not solely rely on vascular smooth muscle cell phenotypic switching but is also related to EndMT, and miR-92a-mediated EndMT is an important mechanism underlying neointimal formation in vein grafts.

journal_name

Exp Cell Res

journal_title

Experimental cell research

authors

Zhong CM,Li S,Wang XW,Chen D,Jiang ZL,Zhang C,He XJ,Huang C,Jiang YJ,Wu QC

doi

10.1016/j.yexcr.2020.112402

subject

Has Abstract

pub_date

2021-01-01 00:00:00

pages

112402

issue

eissn

0014-4827

issn

1090-2422

pii

S0014-4827(20)30655-8

journal_volume

398

pub_type

杂志文章

在线工具

MicroRNA-92a -mediated endothelial to mesenchymal transition controls vein graft neointimal lesion formation.